1,117 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
BioDelivery (BDSI) Q1 Earnings and Sales Beat Estimates http://www.zacks.com/stock/news/303259/biodelivery-bdsi-q1-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-303259 May 11, 2018 - BioDelivery Sciences' (BDSI) reports narrower-than-expected loss in Q1. Sales marginally beat the consensus mark.
Allergan's Growth Is Really Dead https://seekingalpha.com/article/4172729-allergans-growth-really-dead?source=feed_sector_healthcare May 11, 2018 - AGN grew Q1 2018 revenue by 3% Y/Y. Organic growth was practically nil. LOE for U.S. General Medicine has started to materialize. If generic Restasis finally arrives it could amplify AGN's pain. With
Wall Street Rallies on Thursday http://www.gurufocus.com/news/680155/wall-street-rallies-on-thursday- May 10, 2018 - Wall Street Rallies on Thursday, Stocks: ROKU,CTL,XRAY,AGN,MYL,ALB,M,KSS,GPS, release date:May 10, 2018
SVA Plumb Wealth Management, LLC Buys Walt Disney Co, General Electric Co, Allergan PLC, Sells ... http://www.gurufocus.com/news/680152/sva-plumb-wealth-management-llc-buys-walt-disney-co-general-electric-co-allergan-plc-sells-wisdomtree-us-midcap-dividend-fund-ishares-710-year-treasury-bond-etf-wisdomtree-us-smallcap-dividend-fund May 10, 2018 - SVA Plumb Wealth Management, LLC Buys Walt Disney Co, General Electric Co, Allergan PLC, Sells WisdomTree U.S. MidCap Dividend Fund, iShares 7-10 Year Treasury Bond ETF, WisdomTree U.S. SmallCap Dividend Fund, Stocks: DIS,GE,SLB,VBR,BSV,VYM,AGN,BNDX,IDV,CELG,GILD,SNY,, release date:May 10, 2018
Tom Gayner Sells Monsanto, Moody http://www.gurufocus.com/news/679237/tom-gayner-sells-monsanto-moody May 09, 2018 - Tom Gayner Sells Monsanto, Moody, Stocks: MON,MCO,FDS,PCAR,PDCO,AGN,BG, release date:May 09, 2018
Aerie (AERI) Incurs Lower Loss in Q1, Launches Rhopressa http://www.zacks.com/stock/news/302887/aerie-aeri-incurs-lower-loss-in-q1-launches-rhopressa?cid=CS-ZC-FT-302887 May 09, 2018 - Aerie (AERI) reported a narrower-than-expected loss in the first quarter. The launch of the lead drug Rhopressa is underway.
Takeda Closes In on Shire, but It's Not a Done Deal Yet http://www.gurufocus.com/news/678726/takeda-closes-in-on-shire-but-its-not-a-done-deal-yet May 08, 2018 - Takeda Closes In on Shire, but It's Not a Done Deal Yet, Stocks: SHPG,AGN,TSE:4502,XSWX:RO, release date:May 08, 2018
Wunderlich Capital Managemnt Buys GlaxoSmithKline PLC, Alibaba Group Holding, Allergan PLC, ... http://www.gurufocus.com/news/678702/wunderlich-capital-managemnt-buys-glaxosmithkline-plc-alibaba-group-holding-allergan-plc-sells-colgatepalmolive-co-thomson-reuters-corp-ishares-msci-emerging-index-fund May 08, 2018 - Wunderlich Capital Managemnt Buys GlaxoSmithKline PLC, Alibaba Group Holding, Allergan PLC, Sells Colgate-Palmolive Co, Thomson Reuters Corp, iShares MSCI Emerging Index Fund, Stocks: SYY,IEF,GSK,BABA,AGN,MDLZ,DWDP,CL,TRI,EEM,EWI,EWP,, release date:May 08, 2018
Allergan: Sell That Volatility https://seekingalpha.com/article/4171172-allergan-sell-volatility?source=feed_sector_healthcare May 08, 2018 - Volatility remaining elevated due to the restasis situation.It is affecting the share price.Investors should look at other growth areas such as CoolSculpting. Eventually this stock will bottom.
BioDelivery Sciences (BDSI) Q1 Earnings: What to Expect? http://www.zacks.com/stock/news/302782/biodelivery-sciences-bdsi-q1-earnings-what-to-expect?cid=CS-ZC-FT-302782 May 08, 2018 - Investor focus will be on the performance of BioDelivery Sciences' (BDSI) two marketed drugs, Belbuca (chronic pain) and Bunavail (opioid-dependence).

Pages: 123456789...112

<<<Page 4>